Acasti Pharma - Stock Split History | ACST

Stock split history for Acasti Pharma since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Acasti Pharma Annual Stock Splits
Acasti Pharma Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.176B $0.000B
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $59.615B 10.87
Teva Pharmaceutical Industries (TEVA) Israel $10.679B 4.35
Bausch Health Cos (BHC) Canada $9.635B 6.37
Mylan (MYL) United States $8.914B 4.00
Dr Reddy's Laboratories (RDY) India $6.395B 16.78
ASPEN PHARMACR (APNHY) South Africa $3.552B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.149B 11.12
Amphastar Pharmaceuticals (AMPH) United States $0.810B 42.07
Homology Medicines (FIXX) United States $0.532B 0.00
Voyager Therapeutics (VYGR) United States $0.528B 0.00
Akorn (AKRX) United States $0.527B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.510B 0.00
CymaBay Therapeutics (CBAY) United States $0.371B 0.00
Assembly Biosciences (ASMB) United States $0.365B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.245B 0.33
Sol-Gel Technologies (SLGL) Israel $0.156B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.156B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.149B 0.00
Teligent (TLGT) United States $0.034B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00